GS0011: Chemical, biochemical, biotechnological and bacteriological products used in industry, science, agriculture, horticulture, namely, chemicals used for industrial purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases; chemical, biochemical, biotechnological and bacteriological products for use in research and testing laboratories, namely, chemicals used for research purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological preparations for scientific purposes, namely, chemicals used for scientific purposes, polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; diagnostic preparations for scientific purposes; proteins being raw materials; reagents for the preparation or transport of biological molecules for scientific purposes
GS0051: Pharmaceutical, veterinary and sanitary preparations, namely, dietetic beverages, foodstuffs and substances for medical purposes, nutritional additives for medical purposes cultures and preparations of microorganisms for medical, pharmaceutical and veterinary purposes, bacteriological preparations for medical, pharmaceutical and veterinary purposes, medicines for veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, medicines for human purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, biological preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical and biochemical preparations for medical, pharmaceutical and veterinary purposes for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, chemical-pharmaceutical preparations for treating genetic diseases including proliferative disorders such as cancer, immunomodulatory disorders such as immunodeficiency and autoimmune syndromes, single gene disorders such as autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive, Y-linked and Mitochondrial linked diseases, multifactorial and polygenic disorders, infectious diseases including those caused by pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites; diagnostic preparations for medical purposes
GS0091: Scientific apparatus and instruments used in the implementation of biochemical analysis and molecular biology techniques, namely, automated biochemical analyzer, automated protein production and protein purification devices, biochemical, biological automated assay devices, nucleic acid break analyzer, devices for protein-nucleic acid interaction analysis; scientific apparatus and instruments for the mapping of all molecules' biological activities; data processing apparatus; multimedia products, namely, blank magnetic, blank optical, blank image and blank sound recording media; software for recording scientific and medical data on an on-line computer database in the field of pharmaceuticals and biotechnology, for simulation and design of biological and chemical products; apparatus and instruments for non-medical diagnosis, namely, computer hardware, microscopes, spectrometers
Case File Event Statements
11/8/2019 - 6 years ago
38 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILEDType:DENC
11/8/2019 - 6 years ago
37 - DEATH OF INTERNATIONAL REGISTRATIONType:DETH
5/2/2019 - 6 years ago
36 - CHANGE OF NAME/ADDRESS REC'D FROM IBType:ADCH
1/26/2018 - 7 years ago
35 - TOTAL INVALIDATION PROCESSED BY THE IBType:INNT
12/28/2017 - 7 years ago
34 - GENERIC MADRID TRANSACTION SENT TO IBType:XXSS
12/28/2017 - 7 years ago
33 - GENERIC MADRID TRANSACTION CREATEDType:XXCR
12/21/2017 - 7 years ago
32 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATEDType:INTR
4/21/2017 - 8 years ago
31 - CANCELLED SECTION 71Type:C71T
3/27/2014 - 11 years ago
30 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
5/18/2013 - 12 years ago
29 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
2/28/2013 - 12 years ago
28 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
12/15/2010 - 14 years ago
27 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
12/15/2010 - 14 years ago
26 - FINAL DISPOSITION PROCESSEDType:FIMP
12/14/2010 - 14 years ago
25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
9/14/2010 - 15 years ago
24 - REGISTERED-PRINCIPAL REGISTERType:R.PR
6/29/2010 - 15 years ago
23 - PUBLISHED FOR OPPOSITIONType:PUBO
6/9/2010 - 15 years ago
22 - NOTICE OF PUBLICATIONType:NPUB
5/25/2010 - 15 years ago
21 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
5/24/2010 - 15 years ago
20 - EXAMINERS AMENDMENT MAILEDType:CNEA
5/24/2010 - 15 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
5/24/2010 - 15 years ago
18 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
5/24/2010 - 15 years ago
17 - EXAMINERS AMENDMENT -WRITTENType:CNEA
5/24/2010 - 15 years ago
16 - PREVIOUS ALLOWANCE COUNT WITHDRAWNType:ZZZX
5/12/2010 - 15 years ago
15 - ASSIGNED TO LIEType:ALIE
5/3/2010 - 15 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
4/7/2010 - 15 years ago
13 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
4/7/2010 - 15 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
4/7/2010 - 15 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
4/7/2010 - 15 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
10/30/2009 - 16 years ago
9 - REFUSAL PROCESSED BY IBType:RFNT
10/7/2009 - 16 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
10/7/2009 - 16 years ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
10/7/2009 - 16 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
10/6/2009 - 16 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
9/22/2009 - 16 years ago
4 - APPLICATION FILING RECEIPT MAILEDType:MAFR
9/18/2009 - 16 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
9/18/2009 - 16 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS
9/17/2009 - 16 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR